KMYY Pharma Strengthens Leadership & Governance to Accelerate Oncology Pipeline
KMYY Pharmaceutical’s new board, led by a seasoned Chairman and legal rep, drives governance, scientific rigor, and rapid regulatory paths for its PI3K‑δ inhibitor and bispecific T‑cell engager.
3 minutes to read